Introduction Hypertension (HTN) is a leading risk factor influencing the global burden of cardiovascular disease. In spite of the fact that measures such as lifestyle changes and pharmacological treatment reduce blood pressure (BP) and cardiovascular complications, worldwide, the treatment of HTN remains suboptimal with inadequately controlled BP in many patients. In the ReHOT Randomized Study, the prevalence of resistant HTN was 11.7% among Brazilian hypertensive patients, which is in agreement with the prevalence reported in other international studies., According to […]